endpts.com·Apr 20, 2026
Odyssey Therapeutics is making a second attempt at an initial public offering (IPO) a year after its first attempt, having submitted the necessary paperwork on Friday night.
Odyssey Therapeutics' renewed attempt at an IPO indicates a resilient strategy in the biotech market, suggesting potential investor interest in their pipeline or business model. For someone tracking biotech IPOs, this move could be a signal to investigate Odyssey's recent developments or partnerships that may have strengthened their proposition since their previous IPO attempt.